Similar sites
Category
Business ServicesGlobal Rank
N/ARank in 1 month
7.7KEstimate Value
N/Avistage is where leaders learn and grow. we help ceos and business owners grow their business through executive coaching and peer advisory groups.
#networking
#vistage
#vistage group
#business coaching
#business
#leadership development
#leadership
#leadership training
#executive coaching
#business advice
Category
Publishing and PrintingGlobal Rank
N/ARank in 1 month
381Estimate Value
N/ASorry. Description is not currently available
#businesscards
#vistaprint
#vista print
#business
#business cards
#printing
#business resources
#business tools
#printing services
#online printing
Category
News and MediaGlobal Rank
N/ARank in 1 month
162Estimate Value
N/ASorry. Description is not currently available
#revista
#periodicos revistas
#diarios y revistas
#ix inversors
#anne dominique correa
#noticias
#ecuador
Malware Scan Info
Macafee Check : 
Email address with vistagen.com
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
Recent Searched Sites
Un-pop.com (31 seconds ago) / VG
Capitalcitymtg.com (39 seconds ago) / IE
Gb2sh.ru (10 seconds ago) / RU
5th.35awards.com (9 seconds ago) /
Tylertodaymagazine.com (1 mins ago) / US
Worlddancesport.org (31 seconds ago) / US
Pg.df.gov.br (3 mins ago) / BR
Sjhockey.net (38 seconds ago) / US
Shavsstudio.com (2 mins ago) / US
Hotel-america-cannes.hotelmix.it (30 seconds ago) / US
Wiw.ontariondp.ca (46 seconds ago) / US
Update.liquibase.com (41 seconds ago) / US
Theblogmocracy.com (15 seconds ago) / US
Uptownmarkets.twiva.com (21 seconds ago) / US
Vistagen.com (0 seconds ago) / US
Adcardz.com (23 seconds ago) / GI
Polisa.news (20 seconds ago) / US
Nmcdla.org (10 seconds ago) / US
Gloriaromana.com (49 seconds ago) / FR
Bramalobellmore.com (18 seconds ago) / US
Domain Informations
Vistagen.com lookup results from whois.networksolutions.com server:
- Domain created: 2001-08-28T00:12:41Z
- Domain updated: 2024-06-28T06:42:21Z
- Domain expires: 2025-08-28T00:12:41Z 1 Year, 56 Days left
- Website age: 22 Years, 309 Days
- Registrar Domain ID: 76492830_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- NS85.WORLDNIC.COM
- NS86.WORLDNIC.COM
Network
- inetnum : 174.129.0.0 - 174.129.255.255
- name : AMAZON-IAD
- handle : NET-174-129-0-0-2
- status : Reallocated
- created : 2018-04-25
- changed : 2019-08-02
Owner
- organization : Amazon Data Services NoVa
- handle : ADSN-1
- address : Array,Herndon,VA,20171,US
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 680399 |
| namecheap.com | 224489 |
| networksolutions.com | 166122 |
| tucows.com | 137881 |
| publicdomainregistry.com | 88119 |
| whois.godaddy.com | 62267 |
| enomdomains.com | 58221 |
| cloudflare.com | 49364 |
| namesilo.com | 48894 |
| gmo.jp | 46192 |
| register.com | 39024 |
| fastdomain.com | 38301 |
| ionos.com | 33869 |
| name.com | 32288 |
| wildwestdomains.com | 32212 |
| net.cn | 31018 |
| registrar.amazon.com | 30344 |
| dynadot.com | 27920 |
| key-systems.net | 27185 |
Host Informations
| Host name | wwwizer.com |
| IP address | 174.129.25.170 |
| Location | Ashburn United States |
| Latitude | 39.0481 |
| Longitude | -77.4728 |
| Metro Code | 511 |
| Timezone | America/New_York |
| Postal | 20149 |
Port Scanner (IP: 174.129.25.170)
Spam Check (IP: 174.129.25.170) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with vistagen.com on Search Engine
VistaGen Therapeutics Inc. (VTGN): Investing has never been easier
VistaGen Therapeutics Inc. (VTGN) is priced at $0.78 after the most recent trading session. At the very opening of the session, the stock price was $0.9085 and reached a high price of $0.9085, prior to closing the session it reached the value of $0.86. The stock touched a low price of $0.7712.Recently in News on July 12, 2022, VistaGen CEO ...
Investchronicle.comDA: 19 PA: 50 MOZ Rank: 94
VistaGen Therapeutics Company Profile - Craft
VistaGen Therapeutics has 9 employees at their 1 location and $1.11 M in annual revenue in FY 2022. See insights on VistaGen Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
Craft.coDA: 8 PA: 22 MOZ Rank: 31
VistaGen Therapeutics Stock Forecast, Price & News
VistaGen Therapeutics has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.
Marketbeat.comDA: 18 PA: 20 MOZ Rank: 40
Insider Selling: VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Major ...
VistaGen Therapeutics Stock Performance NASDAQ VTGN opened at $0.78 on Friday. The business has a fifty day moving average price of $1.01 and a 200 day moving average price of $1.29.
Defenseworld.netDA: 20 PA: 50 MOZ Rank: 47
VistaGen Therapeutics Inc. - MarketWatch
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing new generation medications that go …
Marketwatch.comDA: 19 PA: 21 MOZ Rank: 44
VistaGen Therapeutics to Report Fiscal Year 2022 Financial Results …
SOUTH SAN FRANCISCO, Calif., June 17, 2022--VistaGen Therapeutics, Inc. (NASDAQ: VTGN) a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other CNS disorders, today announced it will host a conference call and …
Ca.style.yahoo.comDA: 18 PA: 50 MOZ Rank: 79
VistaGen Therapeutics, Inc. (VTGN) Reports Q2 Loss, Tops Revenue …
VistaGen Therapeutics, Inc.Which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.36 million for the quarter ended September 2021, surpassing the Zacks Consensus Estimate by 9.48%. This compares to year-ago revenues of $0.33 million. The company has topped consensus revenue estimates two times over the last …
Ca.yahoo.comDA: 12 PA: 50 MOZ Rank: 85
VistaGen to Participate at William Blair Biotech Focus Conference …
VistaGen Therapeutics, Inc. (Nasdaq: VTGN) (VistaGen), a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders, today announced that Chief Executive Officer Shawn Singh will participate in a panel discussing …
Marketscreener.comDA: 22 PA: 50 MOZ Rank: 43
Insider Selling: VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Major ...
VistaGen Therapeutics Stock Performance Shares of VTGN stock opened at $0.78 on Friday. The firm’s 50-day moving average is $1.01 and its 200-day moving average is $1.29.
Etfdailynews.comDA: 20 PA: 50 MOZ Rank: 42
VistaGen Therapeutics, Inc. (VTGN) Stock Price, News, Quote
SOUTH SAN FRANCISCO, June 02, 2022--VistaGen Therapeutics, Inc. (Nasdaq: VTGN) (VistaGen), a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company aiming to transform ...
Finance.yahoo.comDA: 17 PA: 11 MOZ Rank: 37
VistaGen Therapeutics, Inc. (VTGN) Stock Price, News, Quote
VistaGen to Participate at William Blair Biotech Focus Conference 2022. SOUTH SAN FRANCISCO, Calif., July 07, 2022--VistaGen Therapeutics, Inc. (Nasdaq: VTGN) (VistaGen), a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other …
Ca.finance.yahoo.comDA: 20 PA: 11 MOZ Rank: 41
VTGN VistaGen Therapeutics Inc — Stock Price and Discussion
VTGN 0.78 0.08 (9.60%) Post-Market 0.02 (2.42%) 14,674. Watch. Filter by: Real-Time.
Stocktwits.comDA: 14 PA: 12 MOZ Rank: 37
VistaGen Therapeutics Inc. (NASDAQ: VTGN) - BioMedWire (BMW)
VistaGen Therapeutics Inc. (NASDAQ: VTGN) is a biopharmaceutical company committed to developing and commercializing a new generation of medications that go beyond the standard of care for anxiety, depression and other central nervous system (CNS) disorders. The company is headquartered in South San Francisco, California, the “Birthplace of ...
Biomedwire.comDA: 18 PA: 35 MOZ Rank: 65
VistaGen Therapeutics Inc - Stock Quote VTGN
VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders ...
Morningstar.comDA: 19 PA: 23 MOZ Rank: 55
Stock Market | Pittsburgh Post-Gazette
VistaGen is a late clinical-stage, biopharmaceutical company striving to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than those that are currently available. VistaGen’s clinical-stage …
Markets.post-gazette.comDA: 24 PA: 50 MOZ Rank: 36
Stock Market | FinancialContent Business Page
VistaGen (Nasdaq: VTGN) is a late clinical-stage, CNS-focused biopharmaceutical company striving to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The Company is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those ...
Markets.financialcontent.comDA: 28 PA: 50 MOZ Rank: 35
VistaGen Therapeutics, Inc. (VTGN) Message Board | InvestorsHub
South San Francisco, CA 94080. VistaGen Therapeutics, Inc. (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company committed to developing and commercializing new generation medications that go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders.
Investorshub.advfn.comDA: 22 PA: 37 MOZ Rank: 75
8-K: VistaGen Therapeutics, Inc. - MarketWatch
Item 2.02 Results of Operations and Financial Condition. On June 23, 2022, VistaGen Therapeutics, Inc. (the "Company") issued a press release to announce the Company's financial results for its ...
Marketwatch.comDA: 19 PA: 50 MOZ Rank: 91
Vistagen Therap. Com (VTGN-Q) Quote - The Globe and Mail
VistaGen CEO Joins U.S. Surgeon General to Discuss Mental Health Crisis in America at the 2022 Concordia Americas Summit. Business Wire - Tue Jul 12, 7:30AM CDT. VistaGen Therapeutics, Inc ...
Theglobeandmail.comDA: 23 PA: 33 MOZ Rank: 74
VistaGen Therapeutics, Inc. Common Stock (VTGN) - Nasdaq
Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...
Nasdaq.comDA: 14 PA: 28 MOZ Rank: 61
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| indecabusiness.com | networksolutions.com | 1 Year, 219 Days |
| yuechizhaopin.com | gname.com | 196 Days |
| drolien.com | gmo.jp | 227 Days |